In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 282 for your search:
Drug:  thiotepa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 50 and under
Sponsor: Other
Protocol IDs: MSGCC-9720, NCI-V98-1428

2.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MSGCC-9721, NCI-V98-1438

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 30
Sponsor: Other
Protocol IDs: EUDRACT 2005-002618-40, BfArM-4030755, EC-105/05, DKS 2006.01, DK 2008.17, NCT00749723

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-BS01, EU-94005

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: SCTN-BR9405, EU-95048, NCT00002755

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor: Other
Protocol IDs: CDR0000065151, FRE-FNCLCC-PEGASE03, EU-96032, NCT00002870

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18-physiologic 60
Sponsor: NCI, Other
Protocol IDs: CDR0000065391, CCCWFU-95496, NCI-G97-1145, NCT00002942

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor:
Protocol IDs: SCTN-BR9810, EU-98054, NCT00003680

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: CPMC-IRB-7608, CPMC-CAMP-014, NCI-G00-1890, NCT00008203

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI
Protocol IDs: CLB-8082, CALGB-8082

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 70
Sponsor: NCI
Protocol IDs: CLB-8281, CALGB-8281

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: EST-5181

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-6181

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-10

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-11

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8122

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8215

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7676

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SEG-GU-83321, SEG-GU-83-321

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-30782
1     
New Search